USPTO serial 79227049
KAZIA THERAPEUTICS
Reviewed by CopyMark Law Group
Reg. 5640030Status 706Registered
- Filing date
- Status date
- Registration date
- Jan 1, 2019
- Examiner
- HACK, ANDREA R
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with KAZIA THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sana Hakim
Sana Hakim K&L Gates LLPP.O. Box 1135Chicago, IL 60690-1135United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in science; chemical products for use in the manufacture of pharmaceuticals and medicine; biochemicals, namely, precursors for in vitro genetic engineering use in the field of pharmaceuticals and medicine; chemical preparations for the manufacture of pharmaceuticals; chemicals for use in manufacturing of pharmaceuticals | ACTIVE | — |
| 005 | Pharmaceutical preparations, namely, cytotoxic chemotherapy; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for human use, namely, pharmaceutical compounds for treating cancer; pharmaceutical preparations for treating chemical imbalances; diagnostic preparations for medical purposes | ACTIVE | — |
| 042 | Scientific research services; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceuticals; biotechnology research; biochemical and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the safety of pharmaceuticals, namely, scientific laboratory services for assessing efficacy of pharmaceuticals; scientific research services featuring the preparation of reports thereon; medical analytical laboratory services; laboratory research and analysis in the field of pharmaceuticals; laboratory research and analysis in the field of cancer treatments; development of products; development of new products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; consultancy and information services relating to the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kazia Therapeutics Limited
- Other trademarks owned by Kazia Therapeutics Limited
- Other trademarks owned by Kazia Therapeutics Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named KAZIA THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 9, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 9, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Sep 8, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 3, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jan 1, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 19, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 3, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 15, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 15, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 1, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 15, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jan 1, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 16, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 16, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 12, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Sep 26, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 26, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 26, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 10, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 10, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 10, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 10, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 10, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 4, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Aug 23, 2018 | ALIE | ASSIGNED TO LIE | — |
| Aug 13, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 13, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 13, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 13, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 6, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 6, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 6, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 3, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 1, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 28, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 15, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |